Adenoviral delivery of adiponectin ameliorates osteogenesis around implants in ovariectomized rats. (22nd January 2019)

• Record Type: Journal Article
• Authors: Yin, Guozhu; Liu, Hanghang; Li, Jiayang; Liu, Yao; Liu, Xian; Luo, En
• Is Part Of: Journal of gene medicine. Volume 21:Number 2/3(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-01-22
• Subjects: adenovirus -- adiponectin -- differentiation -- implant -- osseointegration; Genetic transformation -- Periodicals; Gene Transfer -- Periodicals; Gene Therapy -- Periodicals; 616.042
• DOI: 10.1002/jgm.3069
• Languages: English
• ISSNs: 1099-498X

Abstract

Abstract: Background: Adiponectin (APN) has been reported to promote bone formation. However, it is difficult to utilize a conventional method that administers sufficient APN to the implant site. The present study investigated the efficacy of an APN transgene to accelerate the implant osseointegration in ovariectomized (OVX) rats. Methods: In vitro, bone marrow stromal cells were transduced with reconstructed adenovirus (Ad‐APN‐EGFP) and osteoclast precursor RAW264.7 cells were co‐cultured with the conditioned medium secreted by transduced bone marrow stromal cells. Tartrate‐resistant acid phosphatase staining and bone slice resorption assay were performed to evaluate the activity of osteoclastogenesis. In vivo, Ad‐APN‐EGFP was administered into the bone defect prior to implant placement in OVX rats. At 7 and 28 days post implantation, the femurs were harvested and prepared for a real‐time reverse transcriptase‐polymerase chain reaction, hemotoxylin and eosin staining, immunohistochemical staining, micro‐computed tomography analysis and biomechanical testing. Results: The results showed the formation and function of osteoclasts were significantly suppressed in vitro . Successful transgene expression was confirmed, and a significant increase of OCN, Runx2 and ALP expression was detected in the Ad‐APN‐EGFP group in vivo . Interestingly, we also found that the overexpression of APN decreased the expression level of potent adipogenic transcription factors such as PPARγ2 and C/EBP‐α. At 28 days after implantation, the Ad‐APN‐EGFP group revealed a significantly increased osseointegration and implant stability in OVX rats compared to the control groups (Ad‐EGFP and PBS groups). Conclusions: APN via direct adenovirus‐mediated gene transfer could ameliorate osseointegration surrounding titanium implants in OVX‐related osteoporosis rats. Furthermore, it may be an effective strategy for promoting bone regeneration under osteoporotic conditions.